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Demystification of microbial behaviour in mixed biofilms could have a major impact on our
understanding of infectious diseases. The objectives of this study were to evaluate in vitro the
interactions of six different Candida species and a Gram-negative coliform, Escherichia coli, in
dual-species biofilms, and to assess the effect of E. coli LPS on Candida biofilm formation. A
single isolate of E. coli ATCC 25922 and six different species of Candida, Candida albicans
ATCC 90028, Candida glabrata ATCC 90030, Candida krusei ATCC 6258, Candida tropicalis
ATCC 13803, Candida parapsilosis ATCC 22019 and Candida dubliniensis MYA-646, were
studied using a standard biofilm assay. Each Candida species was co-cultured with E. coli on a
polystyrene surface and biofilm formation was quantified by a c.f.u. assay. The biofilm was then
analysed by Live/Dead staining and fluorescence microscopy (confocal laser-scanning
microscopy, CLSM), whilst scanning electron microscopy (SEM) was employed to visualize the
biofilm architecture. The effect of E. coli LPS on Candida biofilm cell activity at defined time
intervals was assessed with an XTT reduction assay. A significant quantitative reduction in c.f.u.
counts of C. tropicalis (after 90 min), C. parapsilosis (after 90 min and 24 h), C. krusei (after
24 h) and C. dubliniensis (after 24 and 48 h) was noted on incubation with E. coli in comparison
with their monospecies biofilm counterparts (P ,0.05). On the other hand, a simultaneous and
significant reduction in E. coli cell numbers occurred on co-culture with C. albicans (after 90 min),
and an elevation of E. coli cell numbers followed co-culture with C. tropicalis (after 24 h) and C.
dubliniensis (after 24 h and 48 h) (P ,0.05). All quantitative findings were confirmed by SEM
and CLSM analyses. By SEM observation, dual-species biofilms demonstrated scanty
architecture with reduced visible cell counts at all stages of biofilm development, despite profuse
growth and dense colonization in their single-species counterparts. Significantly elevated
metabolic activity, as assessed by XTT readings, was observed in E. coli LPS-treated C. tropicalis
and C. parapsilosis biofilms (after 48 h), whilst this had the opposite effect for C. dubliniensis
(after 24 h) (P ,0.05). These data indicate that E. coli and Candida species in a mixed-species
environment mutually modulate biofilm development, both quantitatively and qualitatively, and that
E. coli LPS appears to be a key component in mediating these outcomes.
INTRODUCTION
In nature, most micro-organisms do not exist as pure
species and prefer a lifestyle of community growth with one
or more other species in a complex community organiza-
tion termed a biofilm. By definition, a biofilm is a complex
functional community of one or more species of microbes
encased in an extracellular polymeric network and attached
to one another or to a solid surface (Samaranayake, 2006).
According to the US National Health Institute and the
Centers for Disease Control and Prevention, it has been
estimated that more than 60% of all microbial infections
are associated with biofilms (Lewis, 2001; Potera, 1999).
Some examples of biofilm-related infections include cystic
fibrosis-related infections, catheter-related infections, peri-
odontal diseases and middle ear infections (Douglas, 2003).
Candida, a common commensal fungus of humans, may
convert to an opportunistic pathogen causing superficial or
deep infections in susceptible hosts including neonates,
patients undergoing immunosuppressive or broad-spectrum
antibiotic therapy, or those with indwelling catheters, human
immunodeficiency virus infection and diabetes (Odds, 1987).
Abbreviations: CLSM, confocal laser-scanning microscopy; SEM,
scanning electron microscopy.
A table of c.f.u. counts of Candida species and E. coli from biofilms at
different time intervals is available as supplementary data with the online
version of this paper.
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Indeed, Candida is considered the fourth most commonly
isolated pathogen from bloodstream infections in US
institutions (Banerjee et al., 1991; Jones et al., 1997; Pfaller
et al., 1998) and these infections appear to have, overall, the
highest crude mortality (Crump & Collignon, 2000).
Constitutionally, a biofilm comprises either a single species
(monospecies) or, more usually, multiple species of either
bacteria alone or bacteria together with fungi such as
Candida (multispecies) (Nobile & Mitchell, 2007). The
architecture and functionality of such multispecies biofilms
are complex and the biofilms exhibit interspecies relation-
ships that have yet to be unravelled, as the organisms co-
exist within a community with multifarious demands
(Carlsson, 1997). Most of the work in the literature
investigating such multispecies biofilms is based on multi-
bacterial biofilms and there are few data on the interactions
within fungal–bacterial biofilms. In one of the earliest
studies, Nair & Samaranayake (1996a) demonstrated that
adhesion of Candida albicans to denture acrylic surfaces was
promoted by Escherichia coli, a Gram-negative bacterium. In
subsequent studies, they reported that this coliform
significantly suppressed the adhesion of C. albicans and
Candida krusei to human buccal epithelial cells (Nair &
Samaranayake, 1996b). More recently, the same group
(Thein et al., 2006) confirmed that coliforms such as E. coli
and Pseudomonas aeruginosa can significantly compromise
C. albicans biofilm formation in a dose-dependent manner.
The endotoxin LPS, a cell-wall constituent of all Gram-
negative bacteria including E. coli, possesses immunomo-
dulatory and pro-inflammatory properties (Morrison &
Ryan, 1987; Rietschel et al., 1982). The effect of LPS on
Candida was examined by Akagawa et al. (1995) and Henry-
Stanley et al. (2003), who noted that Candida-associated
mortality of experimental animals was augmented by E. coli
and its LPS. It has been stated that LPS itself has no direct
effect on candidal growth (Palma et al., 1992), but the
immunomodulatory effects may be due to a secondary effect
on polymorphonuclear leukocytes and monocytes (Cohn,
1978; Dahinden et al., 1983; Henricks et al., 1983). To date,
the role of E. coli LPS on Candida–E. colimixed biofilms has
not been evaluated. Furthermore, most of the previous
studies on interactions between Candida and bacteria in
mixed biofilms focused only on C. albicans, and there are no
studies to our knowledge relating to non-albicans Candida
species biofilms in a mixed-species environment.
Hence, the aims of this study were to evaluate the
interactions of E. coli and six different Candida species,
C. albicans, Candida glabrata, Candida tropicalis, Candida
parapsilosis, Candida dubliniensis and C. krusei, in dual-
species biofilms and to assess the effect of E. coli LPS on the
biofilm development of these Candida species.
METHODS
Experimental design. The study comprised two components. First,
a series of experiments was conducted to evaluate the combined effect
of each of six different species of Candida and one isolate of E. coli on
biofilm formation at three different time intervals. Secondly, a series
of experiments was conducted to assess the effect of E. coli LPS on the
biofilm development of the selected Candida species.
Micro-organisms. The following reference laboratory strains of
Candida and E. coli were used: C. albicans ATCC 90028, C. glabrata
ATCC 90030, C. tropicalis ATCC 13803, C. parapsilosis ATCC 22019,
C. krusei ATCC 6258, C. dubliniensis MYA-646 and E. coli ATCC
25922. The identity of each organism was confirmed with the
commercially available API 32C (for Candida strains) and API 20E
(for E. coli) identification systems (bioMe´rieux). All isolates were
stored in multiple aliquots at 220 uC, after confirming their purity.
LPS. LPS purified from E. coli O111 : B4 (Ready Made solution, 1 mg
ml21, 0.2 mm filtered) was purchased from Sigma Aldrich and stored
at 2–8 uC until use.
Growth media. Sabouraud dextrose agar (SDA) and yeast nitrogen
base (YNB) solution supplemented with 100 mM glucose were used
for culturing Candida species, and blood agar, MacConkey agar and
tryptic soy broth (TSB) were utilized for E. coli culture.
Microbial inocula. Prior to each experiment, Candida species and E.
coli were subcultured on SDA and blood agar, respectively, for 18 h at
37 uC. A loopful of this overnight growth was inoculated into YNB
(Candida) or TSB (E. coli) medium and incubated for 18 h in an
orbital shaker (75 r.p.m.) at 37 uC. The resultant growth was
harvested, washed twice in PBS and resuspended in PBS. PBS without
calcium and magnesium ions was used to wash and rinse the
suspended cells, as these ions facilitate cell binding and clumping,
which would mask the mutual effects of Candida and E. coli during
biofilm development. Concentrations of Candida species and E. coli
were adjusted to 16107 cells ml21 by spectrophotometry and were
confirmed by haemocytometric counting.
Biofilm formation. Candida biofilms were developed as described by
Jin et al. (2004) with some modifications. Commercially available pre-
sterilized, polystyrene, flat-bottomed, 96-well microtitre plates
(Iwaki) were used. A standard cell suspension (100 ml) of Candida
species and E. coli (107 cells ml21, 1 : 1 ratio) was prepared and
transferred into selected wells of a microtitre plate. The plate was
incubated for 1.5 h at 37 uC in an orbital shaker at 75 r.p.m. to
promote microbial adherence to the surface of the wells. A volume of
100 ml of monospecies controls of Candida species and E. coli was
inoculated in an identical fashion. After the initial adhesion phase, the
cell suspensions were aspirated and each well was washed twice with
PBS to remove loosely adherent cells. A volume of 200 ml TSB was
added to each well and the plate was reincubated for 24 or 48 h. The
wells were then washed two or three times at respective time intervals
with PBS to eliminate traces of TSB. The bacterial–fungal interactions
were studied at 90 min (adhesion phase), 24 h (colonization phase)
and 48 h (maturation phase) time intervals.
Quantitative analyses
Spiral plating and c.f.u. assay. At the end of the adhesion (90 min),
colonization (24 h) and maturation (48 h) phases, after washing as
described above, 100 ml PBS was added to each well and the biofilm
mass was meticulously scraped off the well wall using a sterile scalpel
(Jin et al., 2004). The resultant suspension containing the detached
biofilm cells was gently vortexed for 1 min to disrupt the aggregates,
serially diluted and inoculated using a spiral plater onto SDA for
Candida species and MacConkey agar for E. coli. The resultant c.f.u.
ml21 of yeast and bacteria were quantified after 48 h incubation at
37 uC. Each assay was carried out in triplicate on three different
occasions.
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Evaluation of the effect of E. coli LPS using an XTT reduction assay. In
the second part of the study, the effect of E. coli LPS on Candida
species was evaluated. Freshly prepared LPS (1 mg ml21, Ready Made
solution; Sigma Aldrich) and YNB supplemented with 100 mM
glucose were mixed to yield a final concentration of 100 mg LPS ml21
in the medium of the test sample. LPS was replaced with sterile PBS in
the control. Candida biofilms were formed in three different 96-well
plates to evaluate the effect of E. coli LPS at 90 min, 24 h and 48 h as
described below.
First, Candida suspension medium (100 ml each) was decanted after
centrifugation, resuspended in test and control medium (see above),
dispersed into selected wells of a 96-well plate at time 0 and incubated in
an orbital shaker (75 r.p.m.) at 37 uC for 90 min for the adhesion assay. In
the second assay, 200 ml test and control medium was added at 90 min to
a different 96-well plate with pre-adherentCandida and incubated for 24 h
for the initial colonization study. Finally, in the third assay, the latter
procedure was repeated at 24 h for initially colonized Candida in a
different 96-well plate and incubated for a further 24 h for the maturation
phase study. At the end of the incubation period, the supernatant was
removed and the wells were washed twice with sterile PBS to remove
loosely adherent cells. A standard XTT reduction assay was performed, as
described by Jin et al. (2004), to measure the metabolic activity of biofilms.
In brief, commercially available XTT powder (Sigma) was dissolved in PBS
to a final concentration of 1 mg ml21. The solution was filter-sterilized
(0.22 mmpore-size filter) and stored at270 uC. Freshly prepared 0.4 mM
menadione solution was used for the XTT reduction assay. XTT solution
was thawed and mixed with menadione solution at a ratio of 20 : 1 (v/v)
immediately before the assay. Thereafter, 158 ml PBS, 40 ml XTT and 2 ml
menadione solution were added to each well containing pre-washed
biofilms and incubated in the dark for 3 h at 37 uC. Colour changes were
measured with a microtitre plate reader (SpectraMax 340 tunable
microplate reader; Molecular Devices) at 492 nm. All assays were carried
out in triplicate on three different occasions.
Qualitative analyses Confocal laser-scanning microscopy (CLSM)
(Jin et al., 2005) and scanning electron microscopy (SEM) were used
to observe the ultrastructure of the Candida and E. coli biofilms.
CLSM. Commercially available pre-sterilized flat-bottomed six-well
plates (Iwaki) and pre-sterilized plastic coverslips (Thermanox; Nulge
Nunc International) (Ramage et al., 2001) were used to prepare
biofilms as described above. Pre-sterilized coverslips were placed in
the wells of a six-well plate, and suspensions of the monospecies or
dual species were added. The plate was incubated for 90 min
(adhesion phase) in an orbital shaker (75 r.p.m.) at 37 uC. Thereafter,
the supernatant was removed, the wells were washed twice with PBS,
fresh TSB was added and the plate was incubated for 24 h (initial
colonization) or 48 h (maturation phase) under the same
environmental conditions. At the end of each time interval, the
pre-washed coverslips were stained with Live/Dead stain (Live/Dead
BacLight Bacterial Viability kit; Invitrogen) (Jin et al., 2005). The
biofilm was then analysed by fluorescence microscopy (by CLSM).
SEM. For SEM, we grew single-species biofilms (Candida or E. coli
alone), as well as Candida and E. coli mixed biofilms, on custom-
made, tissue culture-treated, polystyrene coverslips as described
above. At 90 min, 24 h and 48 h, selected coverslips were removed
from the wells, washed twice with PBS and placed in 1% osmium
tetroxide for 1 h. Samples were subsequently washed in distilled
water, dehydrated in a series of ethanol washes (70% for 10 min,
95% for 10 min and 100% for 20 min) and air dried in a desiccator
prior to sputter coating with gold. Specimens were mounted on
aluminium stubs with copper tape and coated with gold under low
pressure with an ion sputter coater (JFC1 100; JEOL). The surface
topographies of the biofilm were visualized by SEM (Philips XL30CP)
in high-vacuum mode at 10 kV and the images were processed.
Statistical analysis Statistical analysis was performed using SPSS
software (version 16.0). A Mann–Whitney U-test was performed to
compare the significant differences between the control and each test
sample of the bacterial–candidal biofilm. Data from all Candida
species and E. coli analyses at different time points were pooled and
evaluated using a Wilcoxon matched-pairs test. The percentage
modulation of candidal biofilm growth in the presence of E. coli and
E. coli LPS in pooled data was compared using a x2 test. A value of P
,0.05 was considered statistically significant.
RESULTS
Candida and E. coli dual-species biofilm growth
(supplementary Table S1 in JMM Online)
After 90 min of biofilm development with E. coli, a
significant reduction in Candida cell counts was noted with
C. tropicalis (18%, P50.010) and C. parapsilosis (74%,
P50.030) compared with the controls, but this effect was
not seen for C. albicans, C. glabrata, C. dubliniensis or C.
krusei (Fig. 1a). Conversely, after 90 min, a significant
reduction in the number of E. coli c.f.u. (44%, P50.047) was
observed in the presence of C. albicans but not with the other
five Candida species (Fig. 1d).
After prolonged incubation for 24 h, a significant reduc-
tion in the counts of C. krusei (76%, P50.050), C.
parapsilosis (78%, P50.011) and C. dubliniensis (69%, P
,0.001) was noted in dual-species biofilms with E. coli
(Fig. 1b). However, C. albicans, C. tropicalis and C. glabrata
counts were unaffected. On the other hand, the mean
number of E. coli c.f.u. increased significantly in the
presence of C. tropicalis (110%, P50.019) and C.
dubliniensis (11%, P50.017) after 24 h, whilst the other
four Candida species had no significant effect on E. coli
numbers at this time point (Fig. 1e).
On further incubation for 48 h, C. dubliniensis growth was
highly suppressed in dual-species biofilms with E. coli (85%,
P ,0.001), whilst the remaining Candida species were
unaffected (Fig. 1c). Simultaneously, the mean c.f.u. of E.
coli increased dramatically in co-cultures with C. tropicalis
(170%, P50.003) and moderately so with C. glabrata (50%,
P50.042) (Fig. 1f). This effect on E. coli was not seen at this
time point with the four remaining Candida species.
Despite these variable results at different time intervals, when
data from all Candida species were pooled and analysed, a
highly significant inhibition of Candida biofilm formation by
E. coli was noted (P,0.005). Furthermore, there appeared to
be a simultaneous significant enhancement of E. coli biofilm
development at 24 and 48 h time intervals triggered as a result
of cohabitation with Candida (P ,0.005), particularly for C.
tropicalis, C. dubliniensis and C. glabrata.
Effect of E. coli LPS on Candida biofilms (XTT
reduction assay)
In the early biofilm development phase, after 90 min of
incubation, none of the LPS-treated Candida species
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Fig. 1. Mean (±5%) c.f.u. counts of monospecies (Candida species or E. coli) and dual species (Candida species and E. coli) at
different stages of biofilm formation. (a–c) Effect of E. coli on the biofilm formation of each Candida species at 90 min, 24 h and
48 h, respectively. Asterisks indicate a significant (P ,0.05) reduction in mean c.f.u. counts of C. tropicalis (P50.010) and C.
parapsilosis (P50.030) at 90 min (a),C. krusei (P50.050),C. parapsilosis (P50.011) andC. dubliniensis (P,0.001) at 24 h (b)
andC. dubliniensis (P,0.001) at 48 h (c) in the presence of E. coli. (d–f) Effect of eachCandida species on the biofilm formation
of E. coli at 90 min, 24 h and 48 h, respectively. A significant reduction (P,0.05) in mean c.f.u. counts of E. coli was noted in the
presence ofC. albicans (P50.047) at 90 min (d) and a significant enhancement (P,0.05) of mean c.f.u. counts of E. coli withC.
tropicalis (P50.019) and C. dubliniensis (P50.017) at 24 h (e) and C. tropicalis (P50.003) and C. glabrata (P50.042) at 48 h
(f). *, Significant difference between monospecies and dual-species biofilms at a given time point (P ,0.05).
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demonstrated significant changes in metabolic activity
compared with the controls, indicating that LPS has
minimal or no effect on the biofilm metabolism at this
stage. However, after 24 h, the metabolic activity of LPS-
treated C. tropicalis biofilms increased significantly (19%,
P50.008) in contrast to the biofilm activity of C.
dubliniensis, which was significantly suppressed (4%,
P50.004) (Table 1). LPS appeared to have no significant
effect on the other four Candida species at this stage. On
further incubation for 48 h, only LPS-treated C. para-
psilosis biofilm demonstrated increased metabolic activity
(24%, P50.024) compared with the controls (Table 1).
Despite the fact that direct comparisons of data from the
c.f.u. assay and XTT reduction assay cannot easily be made,
we compared the percentage modulation of candidal biofilm
growth in the presence of E. coli and E. coli LPS in pooled
data and found that there was no significant difference
between the percentage modulation of Candida biofilms in
the presence of E. coli or its LPS at any given time point.
CLSM
In 24 h dual-species biofilms, growth suppression of
Candida by E. coli was clearly seen by CLSM with the
Live/Dead stain, confirming the c.f.u. data. Thus, a few
isolated C. krusei blastospores were seen among the cellular
debris after 24 h (Fig. 2d) in contrast to its monospecies
counterpart (Fig. 2c). Similarly, sparsely distributed C.
dubliniensis blastospores were noted in dual-species
biofilms (Fig. 2f) with E. coli after 48 h, confirming the
above quantitative findings. Some dead cells and cellular
debris were also visible compared with the dense mono-
species biofilm growth of the C. dubliniensis control
(Fig. 2e).
With regard to E. coli, CLSM with Live/Dead stain
indicated a reduction in E. coli cell numbers when
incubated with C. albicans for 90 min, confirming the
c.f.u. assay data. A considerable proportion of dead E. coli
cells were visible in these dual-species biofilms (Fig. 2a, b).
When the relative proportions were quantified using image
analysis software, all monospecies biofilms demonstrated a
higher live : dead cell ratio compared with their dual-
species counterparts (data not shown). This indicated
quantitatively that there were fewer live cells and a higher
number of dead cells in dual-species biofilms than in the
monospecies biofilm.
SEM
In general, single-species biofilms of all Candida species
grew well on the substrate on SEM observation, although
species-specific growth variations were noted (Fig. 3).
Thus, during the initial colonization phase of 24 h and the
maturation phase of 48 h, single-species yeast biofilms
characteristically exhibited profuse, dense growth, although
extracellular matrix was scarcely visible (Fig. 3e). In
contrast, at all stages of biofilm formation, dual-species
biofilms demonstrated moderate growth with a reduction
in the cellularity of the biofilm. Thus, in general, the dual-
species biofilm had a reduced number of cell layers, a
higher degree of cellular debris and had degrading yeast
cells (Fig. 3b, d, f).
Table 1. Mean XTT values (±SD) of test (E. coli LPS-treated) and control (LPS-untreated) samples of
different Candida species at 90 min, 24 h and 48 h
Significant differences (P,0.05) are shown in bold.
Candida species Time interval Test (+LPS) Control (”LPS) P value
C. albicans 90 min 0.579±0.091 0.569±0.094 0.795
24 h 0.736±0.142 0.688±0.166 0.453
48 h 1.251±0.041 1.205±0.099 0.312
C. glabrata 90 min 0.781±0.300 0.706±0.238 0.862
24 h 0.920±0.316 0.961±0.303 0.326
48 h 1.268±0.132 1.237±0.082 0.453
C. tropicalis 90 min 0.311±0.015 0.322±0.021 0.149
24 h 0.362±0.055 0.303±0.037 0.008
48 h 0.400±0.094 0.410±0.051 0.507
C. parapsilosis 90 min 0.232±0.046 0.254±0.066 0.248
24 h 0.525±0.250 0.412±0.107 0.862
48 h 1.053±0.220 0.851±0.268 0.024
C. dubliniensis 90 min 0.318±0.032 0.331±0.021 0.453
24 h 0.566±0.008 0.588±0.023 0.004
48 h 0.854±0.171 0.906±0.107 0.402
C. krusei 90 min 0.656±0.169 0.537±0.137 0.106
24 h 1.075±0.353 1.024±0.313 0.862
48 h 1.367±0.101 1.342±0.081 0.644
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With regard to E. coli, a few bacteria were seen and their
density varied depending on the Candida species present
and the different time intervals, and they had a less
nondescript structure in comparison with the monospecies
counterpart (Fig. 3d). Furthermore, the ability of C.
albicans to suppress E. coli colonization in dual-species
biofilms was clearly evident from SEM data (Fig. 3c, d).
DISCUSSION
Candida is a commensal yeast that colonizes oral, intestinal
and vaginal mucosae of humans. The prevalence of
Candida species in oral cavities of healthy adults is
approximately 50% (Samaranayake & MacFarlane, 1990)
and C. albicans is the most common species followed by C.
tropicalis. However, other Candida species such as C.
krusei, C. tropicalis, C. glabrata and C. parapsilosis are also
associated with oral infections (Samaranayake et al., 1987;
Webb et al., 1998). Candida can colonize and develop into
biofilms on animate as well as inanimate surfaces such as
acrylic dentures, stents, shunts and prostheses (e.g. voice,
heart valve, knee), implants (e.g. lens, breast, denture),
endotracheal tubes, pacemakers and various types of
catheter (Cardinal et al., 1996; Gilbert et al., 1996;
Fig. 2. CLSM images of monospecies
(Candida species or E. coli) and dual species
(Candida species and E. coli). Live cells are
stained green and dead cells are red. (a)
Adhesion of E. coli for 90 min. (b) Adhesion of
E. coli in the presence of C. albicans for
90 min. Note the inhibition of E. coli adhesion
by C. albicans in comparison with the mono-
species counterpart. (c) Initial colonization of
C. krusei for 24 h. (d) Initial colonization of C.
krusei co-cultured with E. coli for 24 h. Note
the inhibition of C. krusei colonization by E. coli
compared with the C. krusei monospecies
biofilm. (e) Maturation of C. dubliniensis for
48 h. (f) Maturation of C. dubliniensis when
co-cultured with E. coli for 48 h. Note the
suppression of C. dubliniensis maturation by
E. coli in the dual-species biofilm.
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Goldmann & Pier, 1993; Joly et al., 1997; Leonhardt et al.,
1999; Penk & Pittrow, 1999; Reid et al., 1992; Sen et al.,
1997).
Previous studies have shown that enterobacteria including
E. coli are transient colonizers of the oral cavity and are
more prevalent in Asian than in Western populations (10–
15%) (Samaranayake et al., 1989; Sedgley & Samaranayake,
1994). E. coli is particularly prevalent in the mouth as a
successional community during antibiotic therapy and also
in immunocompromised patients and hospitalized
patients. Despite the frequent association between
Candida and E. coli, few data are available on the
communal behaviour of these two organisms.
The principal aim of this study, therefore, was to evaluate
the qualitative and quantitative effects of the transient oral
colonizer E. coli on various stages of in vitro biofilm
development by six different species of Candida. Our
results indicated that both Candida and E. coli mutually
modulate biofilm development to varying degrees at
different stages of biofilm formation.
Using a c.f.u. assay, we report here, for the first time, the
quantitative effect of E. coli on six different Candida species.
Our results indicated that E. coli had no significant effect on
the adhesion of C. albicans to polystyrene surfaces,
confirming the previous results of Nair & Samaranayake
(1996a). They also demonstrated the enhanced adhesion of
Candida to acrylic surfaces in the presence of E. coli ATCC
25922, irrespective of the bacterial load on the surface, and
suppression of C. krusei adhesion in the presence of a high
concentration of the coliform (105 and 106 cells ml21). Our
results extend their work, as we noted that E. coli suppressed
the adhesion of two other relatively common Candida
species, C. tropicalis and C. parapsilosis. This implies that
Candida–E. coli interactions related to adhesion and
aggregation may be species-specific rather than strain-
related. Further work with multiple strains of Candida from
different species is required to confirm these findings.
Our results also implied that, on further prolonged
incubation during the post-adhesion and biofilm devel-
opment phase, E. coli suppresses the growth of C. krusei, C.
parapsilosis (at 24 h) and C. dubliniensis (at both 24 and
48 h). For C. albicans, although Thein et al. (2006) noted a
significant inhibition of this yeast at high concentrations of
E. coli (2.56106, 56106 and 16107 c.f.u. ml21) at 24 h,
we were unable to confirm this finding.
Fig. 3. SEM images of monospecies
(Candida species or E. coli) and dual species
(Candida species and E. coli). (a) Adhesion of
C. tropicalis (90 min). (b) Adhesion of C.
tropicalis co-cultured with E. coli (90 min).
Note that C. tropicalis cells are smaller in size
and less populous in comparison with the
monospecies counterpart. (c) Adhesion of E.
coli (90 min). (d) Adhesion of E. coli in the
presence of C. albicans (90 min). Note that E.
coli cell numbers are reduced and scantily
distributed in comparison with the monospe-
cies counterpart, and some cells are attached
to Candida blastospores. (e) Initial colonization
of C. tropicalis (24 h). (f) Initial colonization of
C. tropicalis when co-cultured with E. coli
(24 h). The C. tropicalis biofilm was less
organized with a scanty distribution of cells in
the dual-species biofilm, and some degrading
yeast cells were also present. Magnification:
500 (a, b); 2000 (c–f).
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In the second part of this study, we evaluated the effect of
E. coli LPS at different stages of biofilm formation on six
different Candida species. Although the possible effect of
LPS on the cellular layers of the biofilm is difficult to
analyse with an XTT reduction assay, we tested the effect of
LPS on three different growth phases of Candida biofilm
development at 90 min, 24 h and 48 h, as these partially
reflect the metabolic activity of the growth stages in the
biofilm. Palma et al. (1992) were the first to study the anti-
candidal effect of E. coli LPS in vitro, where graded
concentrations of each LPS isolated from the cell walls of E.
coli, Serratia marcescens and Salmonella typhimurium were
added to neutrophils before addition of the target cells (C.
albicans). They noted that LPS over a dose range of 1–
1000 ng ml21 strongly enhanced the anti-candidal activity
of human neutrophils, although LPS itself had no direct
effect on candidal growth at any concentration used. In
contrast, we have reported here that the LPS of E. coli had a
direct modulatory effect on in vitro biofilm formation of
specific Candida species, leading to growth stimulation of
C. tropicalis and C. parapsilosis and inhibition of C.
dubliniensis. This stimulatory/suppressive effect could be
due to altered cell numbers or altered cellular activity in the
formed biofilm, or both. However, such growth stimula-
tory/suppressive effects appeared to be related to the
maturation period of the biofilm. More research is required
to clarify this phenomenon.
Ultrastructural views of both monospecies and dual-species
biofilms confirmed the results obtained from the c.f.u.
assay. Generally, all monospecies biofilms of Candida were
dense, confluent, relatively well defined and uniformly
distributed, with minimal extracellular polymeric materi-
als. In contrast, yeast growth in dual-species biofilms was
less dense with cell clumps, dead cells and cellular debris
indicating the effect of E. coli. In addition to the reduction
in overall cell counts of Candida in dual-species biofilms
with E. coli, all monospecies biofilms demonstrated a
higher live : dead cell ratio compared with their dual-
species counterparts on CLSM fluorescence image analysis.
The dual-species biofilms were less viable than their
monospecies variants, confirming the mutual inhibitory
effect of Candida and E. coli during biofilm development.
A few workers have interpreted the clinical importance
of such findings. Hummel et al. (1975), for instance,
noted that many Gram-negative organisms including
Pseudomonas and E. coli isolated from burns had a degree
of inhibitory effect on C. albicans, although the effect of E.
coli was the most consistent and reproducible. They also
found that this activity was fungistatic and reversible.
In vitro studies have revealed that certain Gram-negative
gut-associated organisms are frequently inhibitory towards
C. albicans (Hummel et al., 1975). Approximately 20% of
E. coli strains were consistently inhibitory to the growth of
C. albicans. These inhibitory E. coli were constantly more
sensitive to a broad range of antibiotics than their non-
inhibitory counterparts. Antibiotic therapy, therefore, may
encourage the overgrowth of fungi not only by reducing
the number of Gram-negative organisms but also by
selectively eliminating those that are most suppressive to
fungal growth (Hummel et al., 1975). Furthermore, viable
E. coli and E. coli LPS may enhance the virulence of
parenteral C. albicans, although there is a probable
protective function of LPS in Candida infections initiated
via the oral route (Henry-Stanley et al., 2003).
In summary, our studies focused principally on the
interactions of Candida and E. coli during different stages
of biofilm development and indicate that E. coli has a
significant growth inhibitory effect on specific Candida
species at various stages of biofilm development. It is also
clear that some Candida species are able to withstand this
effect of E. coli. We also revealed the mutual modulatory
effects between Candida and E. coli and its LPS. Further
work is necessary to explain the molecular basis of these
interactions and to understand the pathobiology of mixed
bacterial–fungal interactions.
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